ORGO ORGANOGENESIS HOLDINGS INC
2026Q1 · CUSIP 68621F102 · Sector: Healthcare & Biotech
Danger · Dual-confirm: breadth + price
Holders
121
Δ holders QoQ
-26
Breadth percentile
Top 94%
Whale holders
68
Δ whales
-8
Inst. holding value
$148M
New positions
16
Closed positions
42
Price momentum (1Q)
-33.7%
Put / Call
0/1
Breadth history (34 quarters)
Past Lit Events & Aftermath 7 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q4 | Top 20% | -33.7% | — |
| 2025Q1 | Top 15% | +38.7% | +85.4% |
| 2024Q1 | Top 19% | -2.6% | +40.9% |
| 2022Q3 | Top 18% | -5.2% | +18.5% |
| 2021Q2 | Top 4% | -22.6% | -48.2% |
| 2021Q1 | Top 8% | -15.2% | -34.4% |
| 2019Q2 | Top 13% | — | — |
Options Sentiment
Put holders
0
QoQ: -1
Call holders
1
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.12
EPS YoY
—
Revenue (TTM)
$0.5B
Revenue YoY
+12.2%
Net margin
0.5%
ROE
1.1%
Debt ratio
26.7%
FCF (TTM)
$17M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.